Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 217
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

What kills elephants at waterholes in Zimbabwe?

Botswana recently experienced severe, highly publicized mortality of elephant, which authorities attribute...

Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

Activating brown fat to improve diabetes and obesity

Diabetes in childhood is life changing, needing daily insulin injections to get strict blood sugar control...

Backer Badge Funded